LABORATORIOS FARMACEUTICOS ROVI, S.A. «12345...» Page 1 out of 6 25/03/2025 10:03 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases again the Spanish version of the presentation related to its strategy update amending slide 57 to be consistent with the English version (which remains unchanged). Register number: 2667 Notification modified by communication number 2666 dated 25/03/2025 (08:00) 25/03/2025 08:00 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases the presentation related to its strategy update because of its 2025 Capital Markets Day Register number: 2666 Notification modified by communication number 2667 dated 25/03/2025 (10:03) 25/02/2025 07:54 LABORATORIOS FARMACEUTICOS ROVI, S.A. On corporate governance The Company informs about the agreements adopted by the Board of Directors. Register number: 2617 25/02/2025 07:49 LABORATORIOS FARMACEUTICOS ROVI, S.A. On P&L The Company releases the full year 2024 financial results presentation. Register number: 2616 25/02/2025 07:47 LABORATORIOS FARMACEUTICOS ROVI, S.A. On P&L The Company releases the press release related to the full year 2024 financial results. Register number: 2615 07/02/2025 07:36 LABORATORIOS FARMACEUTICOS ROVI, S.A. On P&L The Company reports on some of the results expected by the market consensus Register number: 2595 07/11/2024 07:40 LABORATORIOS FARMACEUTICOS ROVI, S.A. On P&L The Company releases the presentation related to the first nine months of 2024 financial results Register number: 2455 07/11/2024 07:38 LABORATORIOS FARMACEUTICOS ROVI, S.A. On P&L The Company releases the press release related to the first nine months of 2024 financial results Register number: 2454 24/10/2024 07:49 LABORATORIOS FARMACEUTICOS ROVI, S.A. On corporate transactions: mergers, acquisitions and others ROVI informs about the conclusion of its strategic review Register number: 2415 31/07/2024 07:38 LABORATORIOS FARMACEUTICOS ROVI, S.A. On P&L The Company releases the presentation related to the financial results for the first half of 2024 Register number: 2355 Page 1 out of 6 «12345...»
